TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Cryogenetics AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
21,146
|
27,109
|
22,025 |
| Financial expenses |
1,040
|
712
|
664 |
| Earnings before taxes |
-3,722
|
5,689
|
2,591 |
| Total assets |
33,669
|
34,605
|
31,172 |
| Current assets |
9,101
|
17,417
|
16,523 |
| Current liabilities |
6,158
|
5,801
|
6,807 |
| Equity capital |
21,491
|
21,210
|
16,979 |
| - share capital |
2,789
|
2,936
|
3,128 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
63.8%
|
61.3%
|
54.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-17.6%
|
21.0%
|
11.8% |
| Return on assets (ROA) |
-8.0%
|
18.5%
|
10.4% |
| Current ratio |
147.8%
|
300.2%
|
242.7% |
| Return on equity (ROE) |
-17.3%
|
26.8%
|
15.3% |
| Change turnover | |||
| Change turnover % |
31%
|
9% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.